Mark Applebaum to Mutation
This is a "connection" page, showing publications Mark Applebaum has written about Mutation.
Connection Strength
0.024
-
Clinical Targeted Next-Generation Panel Sequencing Reveals MYC Amplification Is a Poor Prognostic Factor in Osteosarcoma. JCO Precis Oncol. 2023 03; 7:e2200334.
Score: 0.024